Key Takeaways
- US$1 billion run rate achieved early: Annualized revenue hit the milestone four quarters ahead of the aspirational Q4FY26 target, with FY25 incremental revenue more than double the cumulative addition of the prior three years.
- Record deal intake transforms the backlog: FY25 closed with five large deal wins in Q4 and 14 for the full year, including the largest healthcare deal in company history, a BPaaS construct with ACV well over $50 million. Combined ACV of deal wins rose over 60% YoY.
- Margins inched up again, with a multi-year plan: EBIT margin reached 11.2%, the third consecutive quarter of expansion from 11.0%, and management laid out a path of 50–75 bps annual improvement to close the gap with peers over 3–4 years.
- The UnBPO playbook stakes a claim on AI-era BPO: Launched in Q4, the blueprint reimagines the business model around technology arbitrage rather than labor arbitrage, and early client and analyst reception has been strong.
- What to watch next quarter: Whether the 12%–15% CC revenue growth guidance for FY26 proves conservative given the exit pipeline is up over 30% YoY, and how quickly the staggered ramp of transformative large deals converts into reported revenue.
The US$1 Billion Milestone and FY26 Guidance
- Milestone delivered early: The annualized revenue run rate of US$1 billion was achieved in Q4 FY25, four quarters ahead of the aspirational goal of Q4FY26, and the incremental revenue added in FY25 was more than double the cumulative addition of the previous three years.
- FY26 revenue guidance set at 12%–15% CC: The band is based on line of sight of the business today, does not build in any changes to the macro environment, and includes approximately 3% from inorganic contributions.
- Guidance philosophy prioritizes predictability: Management declined to break out the math behind the upper versus lower end of the band or quantify how much of the required growth is already covered by deals won, emphasizing instead a philosophy of creating sequential predictability and noting that transformative deals have staggered ramp-up curves that convert into reported revenue over an extended period.
- FY26 EBIT margin guided to 11.25%–12.0%: This continues the upward trajectory from 11.0% three quarters ago to 11.2% in Q4, with management targeting 50–75 bps of annual improvement to bring margins in line with peers over the next 3–4 years.
Idnani: "We remain laser-focused in improving our margins by 50 to 75 basis points each year and bringing them in line with our peers over the next 3 to 4 years."
Deal Wins and the BPaaS Construct
- Record large-deal intake: FY25 ended with 14 large deal wins, five of them signed in Q4, and combined ACV of deal wins rose over 60% YoY; the exit pipeline was up over 30% versus Q4FY24.
- Largest-ever healthcare deal: A five-year BPaaS deal from a mid-market North American health plan, a new logo, with steady-state ACV well over $50 million; the company will manage core administration processes end-to-end, orchestrating a consortium of partners under a Per-Member Per-Month pricing model.
- Five of 14 large deals were new logos: The BPaaS deal and four others came from new clients, while the remaining nine expanded existing relationships, including a Top 10 healthcare payer and a top-five UK media and entertainment company.
- Staggered ramp-up changes the revenue shape: Management explicitly asked investors to factor in that transformative deals, including the BPaaS win, have ramp-up curves different from standard deals and will convert into reported revenue over an extended period, adding to longer-range visibility rather than near-term pops.
- Client concentration fell sharply: The share of revenue from the Top 5 clients dropped to 29.4% from 36.4% a year ago, and the Top 10 to 43.7% from 52.6%, reflecting the strategy of positioning as a challenger with a differentiated, technology-first solution.
Idnani: "This is a unique deal in a way where we'll be managing the core administration processes end-to-end in a BPaaS construct, where we are managing a consortium of partners. And this is in line, again, with the UnBPO TM tenant where we said we can't do it all ourselves, but we will be the orchestrator who's managing a symphony of partners to deliver an end outcome to customers itself."
The UnBPO Playbook and AI Strategy
- UnBPO reimagines the BPO model: Announced in Q4, the playbook lays out ten tenets that shift the axis from labor arbitrage to technology arbitrage, with AI as the central lever; management argues the company occupies a sweet spot: large enough to get a seat at the table, small enough to avoid the bureaucracy that slows larger peers.
- Early traction is strong: In the two months since launch, multiple clients and prospects have requested follow-up workshops with senior leadership to explore the tenets, and several industry analysts have published extensively on the concept, improving the company's visibility.
- AI Innovation Lab launched in Australia: The dedicated lab will collaborate with universities on AI, engineering, robotics, and digital initiatives, complementing the new onshore delivery center opened in Melbourne.
- Revenue per employee declined by design: The company consciously increased the share of its workforce in offshore and near-shore locations, which carry lower revenue realization than in-country US, UK, or Australia roles; the margin accretion from this shift has been reinvested into go-to-market and other growth capabilities.
Idnani: "AI can potentially turn the traditional business model of the BPO industry on its head, because it shifts the axis from labor arbitrage to technology arbitrage."
Vertical Performance
| Vertical | Trend | Commentary |
|---|---|---|
| BFS | ▲ Healthy growth | Driven by ramp-up of recent deal wins and seasonal strength in collections; exit pipeline ~20% higher YoY; sales and solutions teams strengthened. |
| Healthcare | ▲ Modest sequential growth, record ACV | Lingering effect of the pre-US-election decision pause in the payer segment depressed recent quarters, but Q4 was a record for ACV won in the vertical; creative, nonlinear deal structures are resonating. |
| CMT | ▲ Fastest-growing segment | Strong traction among leading consumer tech brands in both traditional and newer non-traditional solutions; pipeline balanced across traditional media/communications and digital-first companies. Tech sub-segment growing fastest due to smaller base. |
| Diverse Portfolio | ▼ 9% QoQ decline | Seasonal softness in retail business drove the decline; healthy pipeline in retail and utilities should translate to broad-based growth in coming quarters. |
| North America | ▲ Healthy and broad-based | Growth expected to remain healthy across all three core verticals. |
| Europe | ▼ 3% QoQ decline | Seasonal softness in UK-centric retail; UK clients navigating macro uncertainty are moving faster toward offshore or nearshore models, creating deflation in reported revenue growth. |
| Australia | ▲ Strong growth | Recent deal wins and the new Melbourne delivery center and AI Innovation Lab support an optimistic trajectory. |
- All verticals expected to grow in FY26: Healthcare is expected to lead, utilities will grow on a smaller base so percentage growth will appear higher, financial services will hold steady, and CMT will grow across all three sub-segments.
- CMT margin compression was cost of growth: Margins in CMT came off during FY25 because of new logo signings and initial ramp-ups to get deals to steady state; management sees no cause for concern and expects margins to normalize.
Margin Levers and the Path to Peer-Level Profitability
- Q4 EBIT margin reached 11.2%: This was the third consecutive quarter of expansion, up from 11.0% three quarters ago, and management believes there is opportunity to continue the trajectory.
- 37 margin levers across nine buckets: The plan spans right-shoring, transformation within existing accounts (automation, AI, process excellence), operational parameters (quality, workforce management), shoring up low-margin accounts, rationalizing talent cost, pricing and change requests, reducing attrition and shrinkage, policy changes, and letting go of spare capacity facilities.
- Offshore shift not yet flowing to margins: The conscious decision to increase the offshore and near-shore workforce mix, which lowers revenue per employee, has had its margin accretion offset by deliberate investment in the business, including go-to-market teams; the last three quarters of consistent expansion suggest the reinvestment phase is now yielding operating leverage.
- Large deal margins expected in line: Management said large deals, including the BPaaS win, are expected to meet company margin expectations, though some upfront investments will come into play during ramp-up.
- OCF/EBITDA conversion dipped to 58%: The normal rate is ~65%; the Q4 weakness was due to a slight delay in collections from two clients, and management expects a return to ~65% or slightly better going forward.
Idnani: "We have got roughly about 37 margin levers which sit under these nine broad buckets that I called out."
People, Infrastructure, and Market Share
- Attrition improved to 29.8%: The trailing 12-month rate dropped from 31.4% last quarter, and the trend is expected to continue improving.
- Capex more than doubled in FY25: Over 7,000 seats were added versus 2,000+ in FY24, preparing execution infrastructure for the order wins; management will continue investing in additional capacity in FY26 given the strength of the executable order book and pipeline.
- Market share gained: The company gained almost half a percent of market share over four quarters against its fifteen closest global publicly traded peers, based on trailing four-quarter reported revenues.
- Significant increase in large-client count: The number of clients with US$1 million, US$5 million, and US$10 million in revenue all increased materially from a year ago.
- New logos added: Seven new logos in Q4, including two strategic logos, bringing the FY25 total to 43 new logos including 12 strategic.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 12% to 15% in constant currency terms, including ~3% inorganic | FY26 |
| EBIT margin | 11.25% to 12.0% band | FY26 |
| Annual margin improvement | 50 to 75 bps per year, bringing margins in line with peers | Over next 3–4 years |
| Tax rate | 19% to 21% range | FY26 |
| OCF/EBITDA conversion | Return to ~65% or slightly better | Going forward |
| Capex | Continue investing in additional capacity given strength of executable order book and pipeline | FY26 |
| All verticals | All industries expected to grow; healthcare to lead | FY26 |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Revenue | ₹2,160 crore, 29.4% YoY |
| Revenue (US$) | US$250 million, 24.3% YoY, 0.4% QoQ |
| Constant currency revenue growth | 2.1% QoQ, closing a tad above US$250 million |
| EBIT margin | 11.2%, up 10 bps QoQ and 20 bps YoY |
| Operating profit | ₹240 crore, up 32.4% YoY |
| Net profit | ₹160 crore, 7.4% of revenue |
| Diluted EPS | ₹2.28 |
| FY26 constant currency revenue growth guidance | 12% to 15% |
| FY26 EBIT margin guidance | 11.25% to 12% |
| Large deals signed | 5, with ACV over US$5 million each |
| New logos added | 7, including 2 strategic logos |
| Total headcount | 34,651, net addition of 507 in Q4 |
| Trailing 12-month attrition | 29.8%, down from 31.4% in Q3 |
| BFS vertical constant currency growth | 5% QoQ, 12% YoY |
| CMT vertical constant currency growth | 6% QoQ, 12% YoY |
| Diverse Portfolio constant currency growth | -9% QoQ, primarily due to seasonal retail softness |
| North America constant currency growth | 3% QoQ, 30% YoY |
| Europe constant currency growth | -3% QoQ, mainly due to seasonal softness in UK-centric retail |
| DSOs | 70 days, normalized 67 days excluding delayed collections |
| Net debt | ₹1,320 crore, vs ₹1,020 crore in Q3 and ₹600 crore in Q4 FY24 |
| Tax rate | 20.3%; FY26 expected range 19-21% |
| Top 5 client revenue share | 29.4%, down from 36.4% in Q4 FY24 |
| Top 10 client revenue share | 43.7%, down from 52.6% in Q4 FY24 |